中文版 | English
题名

Garcinone E suppresses breast cancer growth and metastasis by modulating tumor-associated macrophages polarization via STAT6 signaling

作者
通讯作者Zhang,Jinming; Li,Jingjing
发表日期
2023
DOI
发表期刊
ISSN
0951-418X
EISSN
1099-1573
摘要
Cancer metastasis remains the most common cause of death in breast cancer patients. Tumor-associated macrophages (TAMs) are a novel therapeutic target for the treatment of metastatic breast cancer. Despite the good anti-cancer activity of garcinone E (GE), there are no reports on its therapeutic effects on breast cancer metastasis. The objective of this study was to examine the anti-cancer effects of GE on metastatic breast cancer. RAW 264.7 and THP-1 cells were polarized to M2 macrophages by IL-4/IL-13 in vitro. A 4T1 mouse breast cancer model and the tail vein breast cancer metastasis model were used to explore the effect of GE on breast cancer growth and metastasis in vivo. In vitro studies showed that GE dose-dependently suppressed IL-4 + IL-13-induced expression of CD206 in both RAW 264.7 cells and differentiated THP-1 macrophages. However, GE did not affect the LPS + IFN-γ-induced polarization to the M1-like macrophages in vitro. GE inhibited the expression of the M2 macrophage specific genes in RAW 264.7 cells, and simultaneously impaired M2 macrophage-induced breast cancer cell proliferation and migration, and angiogenesis. In animal studies, GE significantly suppressed tumor growth, angiogenesis, and lung metastasis in 4T1 tumor-bearing mice, without causing toxicity. In both tumor and lung tissues, the proportion of M2-like TAMs was significantly decreased while the proportion of M1-like TAMs was markedly increased by GE treatment. Mechanistically, GE inhibited phosphorylation of STAT6 in vitro and in vivo. Our results demonstrate for the first time that GE suppresses breast cancer growth and pulmonary metastasis by modulating M2-like macrophage polarization through the STAT6 signaling pathway.
关键词
相关链接[Scopus记录]
收录类别
语种
英语
学校署名
其他
WOS记录号
WOS:000999224400001
ESI学科分类
PHARMACOLOGY & TOXICOLOGY
Scopus记录号
2-s2.0-85161360448
来源库
Scopus
引用统计
被引频次[WOS]:7
成果类型期刊论文
条目标识符http://sustech.caswiz.com/handle/2SGJ60CL/560296
专题南方科技大学第一附属医院
作者单位
1.State Key Laboratory of Southwestern Chinese Medicine Resources,School of Pharmacy,Chengdu University of Traditional Chinese Medicine,Chengdu,China
2.State Key Laboratory of Quality Research in Chinese Medicine and Institute of Chinese Medical Sciences,University of Macau,Macao
3.Department of Pharmacology and Pharmacy,Li Ka Shing Faculty of Medicine,The University of Hong Kong,Hong Kong
4.Department of Interventional Radiology,Shenzhen People's Hospital (The Second Clinical Medical College,Jinan University; The First Affiliated Hospital,Southern University of Science and Technology),Shenzhen,China
5.Department of Food Science and Nutrition,Faculty of Science,Hong Kong Polytechnic University,Hong Kong
6.The Research Center for Chinese Medicine Innovation,Hong Kong Polytechnic University,Hong Kong
7.Department of Rehabilitation Sciences,Faculty of Health and Social Sciences,Hong Kong Polytechnic University,Hong Kong
推荐引用方式
GB/T 7714
Nie,Xin,Fu,Li,Cheng,Yanfen,et al. Garcinone E suppresses breast cancer growth and metastasis by modulating tumor-associated macrophages polarization via STAT6 signaling[J]. Phytotherapy Research,2023.
APA
Nie,Xin.,Fu,Li.,Cheng,Yanfen.,Wu,Xiaoping.,Lv,Kongpeng.,...&Li,Jingjing.(2023).Garcinone E suppresses breast cancer growth and metastasis by modulating tumor-associated macrophages polarization via STAT6 signaling.Phytotherapy Research.
MLA
Nie,Xin,et al."Garcinone E suppresses breast cancer growth and metastasis by modulating tumor-associated macrophages polarization via STAT6 signaling".Phytotherapy Research (2023).
条目包含的文件
条目无相关文件。
个性服务
原文链接
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
导出为Excel格式
导出为Csv格式
Altmetrics Score
谷歌学术
谷歌学术中相似的文章
[Nie,Xin]的文章
[Fu,Li]的文章
[Cheng,Yanfen]的文章
百度学术
百度学术中相似的文章
[Nie,Xin]的文章
[Fu,Li]的文章
[Cheng,Yanfen]的文章
必应学术
必应学术中相似的文章
[Nie,Xin]的文章
[Fu,Li]的文章
[Cheng,Yanfen]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
[发表评论/异议/意见]
暂无评论

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。